Calendar

Apr 25, 2026phase 1 completion108d agoBristar Immunotech Biotechnology Co Ltd — YTS-109 (Phase I Trial Completion)YTS-109

Therapy area: Hematological Disorders, Immunology. Indication: Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura), Lupus Nephritis, Thrombocytopenia

full page →YTS-109 →source: globaldata

Apr 25, 2026phase 2 completion108d agoEmami Ltd — Himani fast relief gel (Phase II Trial Completion)Himani fast relief gel

Therapy area: Central Nervous System, Immunology, Musculoskeletal Disorders. Indication: Inflammation, Myalgia (Muscle Pain), Unspecified Musculoskeletal Disorders

full page →Himani fast relief gel →source: globaldata

Apr 25, 2026phase 2 initiation108d agoKIMS Hospital — bifidobacterium (Phase II Trial Initiation)bifidobacterium

Therapy area: Immunology. Indication: Plaque Psoriasis (Psoriasis Vulgaris), Psoriasis

full page →bifidobacterium →source: globaldata

Apr 25, 2026phase 3 initiation108d agoDr. Reddy's Laboratories Ltd — olokizumab (Phase III Trial Initiation)olokizumab

Therapy area: Immunology. Indication: Rheumatoid Arthritis

full page →olokizumab →source: globaldata

Week of Apr 20, 2026